StockData
MiNK Therapeutics, Inc. logo

MiNK Therapeutics, Inc. (INKT) stock

INKTNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30
$9.35+0.01 (+0.11%)

Close on Nov 16, 2026Market cap $47.71MP/E –Yield –

MiNK Therapeutics enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

MiNK Therapeutics's enterprise value was $43.30M on Nov 11, 2026, against $33.46M a year earlier. Over the last 5 years it ranged from $2.46M to $107.02M, with a median of $36.43M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$43.30M+20.0%
2025Dec 31, 2025$36.07M+89.0%
2024Dec 31, 2024$19.09M-36.7%
2023Dec 29, 2023$30.16M-51.5%
2022Dec 30, 2022$62.25M-41.8%
2021Dec 31, 2021$107.02M–

More MiNK Therapeutics figures

See a number that looks wrong?